Suchergebnisse - "Spiekermann, Karsten"

PubPharm (316)

61

Impact of IDH1 and IDH2 mutational subgroups in AML patients after allogeneic stem cell transplantation

enthalten in: Journal of hematology & oncology | 2022

von Kunadt, D. | Stasik, S. | Metzeler, K. | +44

62

Impact of IDH1 and IDH2 mutational subgroups in AML patients after allogeneic stem cell transplantation

enthalten in: Journal of hematology & oncology | 2022

von Kunadt, D. | Stasik, S. | Metzeler, K. | +43

63

Thrombocytopenia and splenic platelet-directed immune responses after IV ChAdOx1 nCov-19 administration

enthalten in: Blood | 2022

von Nicolai, L. | Leunig, A. | Pekayvaz, K. | +22

CommentIn: Blood. 2022 Aug 4;140(5):413-414. - PMID 35925641

64

Allogeneic hematopoietic cell transplantation in acute myeloid leukemia with intermediate-risk - results of the randomized ETAL-1 trial

enthalten in: ResearchSquare.com | 2022

von Bornhauser, M. | Schliemann, C. | Schetelig, J. | +26

65

Treatment, outcome and re-vaccination of patients with SARS-CoV-2 vaccine-associated immune thrombocytopenia

enthalten in: ResearchSquare.com | 2022

von Ruzicka, M. | Wurm, S. | Lindner, L. | +9

66

Differential impact of IDH1/2 mutational subclasses on outcome in adult AML : results from a large multicenter study

enthalten in: Blood advances | 2022

von Middeke, J. | Metzeler, K. | Röllig, C. | +43

67

Seasonal community acquired respiratory viruses (CARV) are associated with a high burden of disease in patients with malignancies : preliminary data of the OncoReVir registry

enthalten in: Oncology research and treatment | 2022

von Rüthrich, M. | Schmitt, T. | Claßen, A. | +13

68

Charakterisierung der Rolle von KDM6A-Zielgenen hinsichtlich der Zytostatikaresistenz in AML-Patient*innen

Erschienen: Dissertation, München, Ludwig-Maximilians-Universität, 2022

von Hanneforth, A. | Spiekermann, K.

69

Bcl‐x L as prognostic marker and potential therapeutic target in cholangiocarcinoma

enthalten in: Liver International | 2022

von Hoffmeister‐Wittmann, P. | Mock, A. | Nichetti, F. | +45

70

Targeting intracellular WT1 in AML with a novel RMF-peptide-MHC-specific T-cell bispecific antibody

enthalten in: Blood | 2021

von Augsberger, C. | Hänel, G. | Xu, W. | +33

CommentIn: Blood. 2021 Dec 23;138(25):2598-2599. - PMID 34940819